Why Oral GLP-1 Drugs Could Change Diabetes Care
GLP-1 medications are currently the talk of the town. If you live with type 2 diabetes, you've probably heard a lot about these and…
Are you or your child at risk of developing Type 1 Diabetes? This study is testing a once-daily investigational oral medication (or placebo) to see if it can slow the immune system’s attack on insulin-producing cells and delay the onset of Stage 3 Type 1 Diabetes. There are currently no oral treatments available to prevent or delay this stage.
To take part in the study, participants should:
CEO and Medical Director
Director of Clinical Research
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator